A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Northside Hospital Opens Fifth Health Choice Urgent Care Center in Chamblee, Georgia

Northside Hospital and Urgent Care Group announce the opening of Health Choice Urgent Care in Chamblee, Georgia.

The Northside and Urgent Care Group joint venture now owns and operates five Health Choice Urgent Care centers serving the Greater Atlanta area. Health Choice Urgent Care has been voted Best of Gwinnett four years in a row and Health Choice – Chamblee is the joint-venture’s first center in Dekalb county.

Health Choice – Chamblee, along with all other Health Choice centers, offer walk-in urgent care and occupational health services 7 days a week from 8:00 AM – 8:00 PM. Additionally, Health Choice centers accept all major insurance, have affordable self-pay options and are VA Authorized urgent care providers. For more information about services and locations, please visit here.

“We are pleased to continue to grow our partnership with Northside Hospital through the opening of Health Choice – Chamblee,” said David Maloney, CEO of Urgent Care Group. “Health Choice will offer the Chamblee community access to convenient and affordable on-demand healthcare. Our team is ready and excited to welcome patients into our new center!”

Health Choice Urgent Care will be celebrating the new Chamblee center with a ribbon cutting ceremony on November 10, 2021, at 1:00 PM ET. This event will take place at Health Choice – Chamblee, 5255 Peachtree Blvd Suite 102 Chamblee, GA 30341 on the Ground floor of The Attiva apartment building, across from Dyer & Dyer Volvo.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy